Liu et al. (2018a) suggest a potential application of the exosomal RNA NEAT1 as a biomarker for the diagnosis and subsequent treatment of IBD, however detailed examination of the mechanisms underlying the participation of NEAT1 in the pathogenesis of IBD are still needed. This evidence concerns the gene NEAT1 and inflammatory bowel disease.